RVMD
Price
$95.91
Change
-$0.60 (-0.62%)
Updated
Feb 5, 03:44 PM (EDT)
Capitalization
18.66B
25 days until earnings call
Intraday BUY SELL Signals
STRO
Price
$13.87
Change
-$1.02 (-6.85%)
Updated
Feb 5, 03:37 PM (EDT)
Capitalization
126.85M
35 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

RVMD vs STRO

Header iconRVMD vs STRO Comparison
Open Charts RVMD vs STROBanner chart's image
Revolution Medicines
Price$95.91
Change-$0.60 (-0.62%)
Volume$780
Capitalization18.66B
Sutro Biopharma
Price$13.87
Change-$1.02 (-6.85%)
Volume$100
Capitalization126.85M
RVMD vs STRO Comparison Chart in %
RVMD
Daily Signal:
Gain/Loss:
STRO
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
RVMD vs. STRO commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RVMD is a Hold and STRO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (RVMD: $96.51 vs. STRO: $14.89)
Brand notoriety: RVMD and STRO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RVMD: 64% vs. STRO: 80%
Market capitalization -- RVMD: $18.66B vs. STRO: $126.85M
RVMD [@Biotechnology] is valued at $18.66B. STRO’s [@Biotechnology] market capitalization is $126.85M. The market cap for tickers in the [@Biotechnology] industry ranges from $119.38B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RVMD’s FA Score shows that 0 FA rating(s) are green whileSTRO’s FA Score has 1 green FA rating(s).

  • RVMD’s FA Score: 0 green, 5 red.
  • STRO’s FA Score: 1 green, 4 red.
According to our system of comparison, both RVMD and STRO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RVMD’s TA Score shows that 3 TA indicator(s) are bullish while STRO’s TA Score has 2 bullish TA indicator(s).

  • RVMD’s TA Score: 3 bullish, 5 bearish.
  • STRO’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, RVMD is a better buy in the short-term than STRO.

Price Growth

RVMD (@Biotechnology) experienced а -0.84% price change this week, while STRO (@Biotechnology) price change was -4.61% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.81%. For the same industry, the average monthly price growth was +0.47%, and the average quarterly price growth was +32.90%.

Reported Earning Dates

RVMD is expected to report earnings on Mar 02, 2026.

STRO is expected to report earnings on Mar 12, 2026.

Industries' Descriptions

@Biotechnology (-3.81% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RVMD($18.7B) has a higher market cap than STRO($127M). STRO YTD gains are higher at: 28.695 vs. RVMD (21.168). STRO has higher annual earnings (EBITDA): -166.43M vs. RVMD (-1.02B). RVMD has more cash in the bank: 1.93B vs. STRO (168M). STRO has less debt than RVMD: STRO (17.7M) vs RVMD (158M). STRO has higher revenues than RVMD: STRO (106M) vs RVMD (0).
RVMDSTRORVMD / STRO
Capitalization18.7B127M14,724%
EBITDA-1.02B-166.43M615%
Gain YTD21.16828.69574%
P/E RatioN/AN/A-
Revenue0106M-
Total Cash1.93B168M1,150%
Total Debt158M17.7M893%
FUNDAMENTALS RATINGS
RVMD vs STRO: Fundamental Ratings
RVMD
STRO
OUTLOOK RATING
1..100
9025
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
21
Undervalued
PROFIT vs RISK RATING
1..100
38100
SMR RATING
1..100
97100
PRICE GROWTH RATING
1..100
3638
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
3385

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

STRO's Valuation (21) in the Pharmaceuticals Major industry is significantly better than the same rating for RVMD (96) in the null industry. This means that STRO’s stock grew significantly faster than RVMD’s over the last 12 months.

RVMD's Profit vs Risk Rating (38) in the null industry is somewhat better than the same rating for STRO (100) in the Pharmaceuticals Major industry. This means that RVMD’s stock grew somewhat faster than STRO’s over the last 12 months.

RVMD's SMR Rating (97) in the null industry is in the same range as STRO (100) in the Pharmaceuticals Major industry. This means that RVMD’s stock grew similarly to STRO’s over the last 12 months.

RVMD's Price Growth Rating (36) in the null industry is in the same range as STRO (38) in the Pharmaceuticals Major industry. This means that RVMD’s stock grew similarly to STRO’s over the last 12 months.

RVMD's P/E Growth Rating (100) in the null industry is in the same range as STRO (100) in the Pharmaceuticals Major industry. This means that RVMD’s stock grew similarly to STRO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RVMDSTRO
RSI
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 15 days ago
81%
Bullish Trend 4 days ago
79%
Declines
ODDS (%)
Bearish Trend 11 days ago
74%
Bearish Trend 8 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
68%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
RVMD
Daily Signal:
Gain/Loss:
STRO
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SMOT37.160.62
+1.70%
VanEck Morningstar SMID Moat ETF
BSVO26.050.22
+0.84%
EA Bridgeway Omni Small-Cap Value ETF
HYKE25.48N/A
N/A
Vest 2 Year Interest Rate Hedge ETF
PBL30.97-0.13
-0.41%
PGIM Portfolio Ballast ETF
ARCX28.97-2.23
-7.15%
Tradr 2X Long ACHR Daily ETF

RVMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, RVMD has been closely correlated with ERAS. These tickers have moved in lockstep 86% of the time. This A.I.-generated data suggests there is a high statistical probability that if RVMD jumps, then ERAS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RVMD
1D Price
Change %
RVMD100%
+0.56%
ERAS - RVMD
86%
Closely correlated
+6.19%
TERN - RVMD
85%
Closely correlated
-6.39%
ATOS - RVMD
83%
Closely correlated
-4.34%
IPSC - RVMD
82%
Closely correlated
-2.72%
STRO - RVMD
82%
Closely correlated
+0.40%
More

STRO and

Correlation & Price change

A.I.dvisor indicates that over the last year, STRO has been closely correlated with ATOS. These tickers have moved in lockstep 89% of the time. This A.I.-generated data suggests there is a high statistical probability that if STRO jumps, then ATOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STRO
1D Price
Change %
STRO100%
+0.40%
ATOS - STRO
89%
Closely correlated
-4.34%
CANF - STRO
87%
Closely correlated
-0.25%
PMN - STRO
87%
Closely correlated
-1.57%
PHGE - STRO
87%
Closely correlated
-7.36%
ANL - STRO
81%
Closely correlated
+7.23%
More